Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms by Site × Methods × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 43 Neoplasms 34 Colorectal Neoplasms 23 Lung Neoplasms 22 Uterine Cervical Neoplasms 13 Prostatic Neoplasms 13 Motor Activity 12 Colonic Neoplasms 10 Rectal Neoplasms 8 Pancreatic Neoplasms 8 Lymphoma 8 Carcinoma, Non-Small-Cell Lung 8 Anxiety Disorders 8 Obesity 7 Hematologic Neoplasms 7 Depression 7 Vulvar Neoplasms 6 Melanoma 6 Head and Neck Neoplasms 6 Endometrial Neoplasms 6 Breast Carcinoma In Situ 6 Urinary Bladder Neoplasms 5 Pain 5 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Hematopoietic and Lymphoid System Neoplasm 4 Fatigue 4 Carcinoma, Ovarian Epithelial 4 Vaginal Neoplasms 3

Interventions

Pemetrexed 9 Carboplatin 8 Cisplatin 7 130-nm albumin-bound paclitaxel 7 pembrolizumab 6 Nivolumab 6 durvalumab 5 Paclitaxel 5 Gemcitabine 5 padeliporfin 4 napabucasin 4 Irinotecan 4 Fulvestrant 4 Cyclophosphamide 4 Bevacizumab 4 ribociclib 3 palbociclib 3 osimertinib 3 cobimetinib 3 atezolizumab 3 Trastuzumab 3 Sunitinib 3 Radiosurgery 3 Drug Therapy 3 Docetaxel 3 Anastrozole 3 Albumin-Bound Paclitaxel 3 selpercatinib 2 pralsetinib 2 patritumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03569605 2021-04-01

IMPACT

UNC Lineberger Comprehensive Cancer Center

Phase NA Completed

Motor Activity, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon ⚡